Wedbush analysts removed Uber (UBER) from the firm’s “Best Idea List” but maintains an Outperform rating on the name with an $86 price target ...
In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback